|
|
|
|
Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrha
You can also purchase online an Individual or Institutional Subscription to this journal or buy one or more printed volumes.Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid...
|
|
|
Coronary Vasospasm Underlies Chest Pain in Parvovirus B19 Myocarditis
_ Coronary Vasospasm Underlies Chest Pain in Parvovirus B19 Myocarditis.
|
|
|
Stroke unit patients go home earlier
Stroke 2008; Advance online publication MedWire News: Implementation of stroke unit care in clinical practice reduces patients length of stay in hospital, as well as their in-hospital mortality, say researchers from the Calgary Stroke...
|
|
|
Ensuring Safety of Imaging Drugs Needs Pharma
SeattleThe interventional radiology suite and gastrointestinal (GI) imaging lab are not often on pharmacists radar screens, but they should be, according to Illinois pharmacist Peggy Bickham, PharmD.Potentially life-threatening...
|
|
|
Aires Pharmaceuticals Signs Key Technology License Agreement With the National Institutes of Health
- (NewsRx.com) -- Aires Pharmaceuticals Inc., a drug development company focused on developing therapies for pulmonary conditions, announced the signing of an exclusive license agreement with the U.S.National Institutes of Health for the...
|
|
|
Changes in Amyloid Beta Protein Correlate with Neurological Status After Brain Injury
Investigators reported that in patients with traumatic brain injury, amyloid beta levels dropped when their neurological condition worsened, but were raised when they improved.People who have had a traumatic brain injury (TBI) may be at...
|
|
|
Aires Pharmaceuticals Signs Key Technology License Agreement With the National Institutes of Health
- (NewsRx.com) -- Aires Pharmaceuticals Inc., a drug development company focused on developing therapies for pulmonary conditions, announced the signing of an exclusive license agreement with the U.S.National Institutes of Health for the...
|
|
|
United States: Aires Pharmaceuticals signs technology license agreement with NIH
ires Pharmaceuticals, a drug development company focused on developing therapies for pulmonary conditions, has signed an exclusive licensing agreement with the US National Institutes of Health for the patented use of a nitric oxide prodrug...
|
|
|
Management of post-subarachnoid hemorrhage vasospasm
_ Management of post-subarachnoid hemorrhage vasospasm.
|
